<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14629">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02916446</url>
  </required_header>
  <id_info>
    <org_study_id>REALISE</org_study_id>
    <nct_id>NCT02916446</nct_id>
  </id_info>
  <brief_title>Safety Study of Viaskin Peanut to Treat Peanut Allergy</brief_title>
  <acronym>REALISE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>DBV Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>DBV Technologies</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety of Viaskin Peanut 250 mcg in the treatment of peanut allergy
      in children from 4 to 11 years of age. Subjects will receive either Viaskin Peanut 250 mcg
      or a placebo for a period of 6 months, after which all subjects will be receiving the active
      treatment up to a period of 3 years under active treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adverse Events (AEs), Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)</measure>
    <time_frame>Through study completion, an average of 3 years</time_frame>
  </primary_outcome>
  <other_outcome>
    <measure>Change in peanut-specific Immunoglobulins E (IgE)</measure>
    <time_frame>Baseline, month 3, 6, 9, 12, 18, 24, 30, 36, 42</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Change in peanut-specific Immunoglobulins G4 (IgG4)</measure>
    <time_frame>Baseline, month 3, 6, 9, 12, 18, 24, 30, 36, 42</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">335</enrollment>
  <condition>Peanut Allergy</condition>
  <arm_group>
    <arm_group_label>Viaskin Peanut 250 mcg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Viaskin Peanut 250 mcg, daily administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo patch, daily administration</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Viaskin Peanut 250 mcg</intervention_name>
    <arm_group_label>Viaskin Peanut 250 mcg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physician-diagnosed peanut allergy;

          -  A peanut Skin Prick Test (SPT) with a wheal largest diameter ≥8 mm;

          -  A specific-peanut Immunoglobulin E (IgE) ≥14 kU/L;

          -  Subjects following a strict peanut-free diet.

        Exclusion Criteria:

          -  Generalized dermatologic disease

          -  Spirometry forced expiratory volume in 1 second (FEV1) &lt;80% of the predicted value,
             or peak expiratory flow (PEF) &lt;80% of predicted value;

          -  Receiving β-blocking agents, angiotensin-converting enzyme inhibitors,
             angiotensin-receptor blockers, calcium channel blockers or tricyclic antidepressant
             therapy; anti-tumor necrosis factor drugs or anti-IgE drugs (such as omalizumab) or
             any biologic immunomodulatory therapy;

          -  Prior or concomitant history of any immunotherapy to any food allergy (for example
             EPIT, OIT, SLIT, or specific oral tolerance induction).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stacie M. Jones, MD</last_name>
      <phone>501-364-1060</phone>
      <email>JonesStacieM@uams.edu</email>
    </contact>
    <investigator>
      <last_name>Stacie M. Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allergy &amp; Asthma Associates of Southern California</name>
      <address>
        <city>Mission Viejo</city>
        <state>California</state>
        <zip>92691</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Berger, MD</last_name>
      <phone>949-364-2900</phone>
      <email>weberger@uci.edu</email>
    </contact>
    <investigator>
      <last_name>William Berger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palos Verdes Medical Group</name>
      <address>
        <city>Rolling Hills Estates</city>
        <state>California</state>
        <zip>90274</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lawrence Sher, MD</last_name>
      <phone>310-265-1623</phone>
      <email>lawrence.sher@peninsularesearch.com</email>
    </contact>
    <investigator>
      <last_name>Lawrence Sher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sharon Chinthrajah, MD</last_name>
      <email>snpcenterallergy.inquiry@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Sharon Chinthrajah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David M. Fleischer, MD</last_name>
      <phone>720-777-2575</phone>
      <email>david.fleischer@childrenscolorado.org</email>
    </contact>
    <investigator>
      <last_name>David M. Fleischer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Jewish Health</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Lanser, MD</last_name>
      <phone>303-398-1379</phone>
      <email>lanserb@NJHealth.org</email>
    </contact>
    <investigator>
      <last_name>Bruce Lanser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sarasota Clinical Research</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugh Windom, MD</last_name>
      <phone>941-927-4888</phone>
      <email>Hugh@Windom.allergy.com</email>
    </contact>
    <investigator>
      <last_name>Hugh Windom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Allergy &amp; Asthma Clinic</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanley Fineman, MD</last_name>
      <phone>770-427-1471</phone>
      <email>sfineman@atlantaallergy.com</email>
    </contact>
    <investigator>
      <last_name>Stanley Fineman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of CHicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Catalano</last_name>
      <phone>312-227-6474</phone>
      <email>allergystudy@luriechildrens.org</email>
    </contact>
    <investigator>
      <last_name>Jacqueline Pongracic, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sneeze, Wheeze and Itch Associates,Clinical Research</name>
      <address>
        <city>Normal</city>
        <state>Illinois</state>
        <zip>62704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dareen Siri, MD</last_name>
      <phone>309-452-0995</phone>
      <email>drsiri@asthma2.com</email>
    </contact>
    <investigator>
      <last_name>Dareen Siri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Wood, MD</last_name>
      <phone>410-955-5883</phone>
      <email>rwood@jhmi.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Wood, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wayne Shreffler, MD</last_name>
      <phone>617-726-6147</phone>
      <email>wshreffler@partners.org</email>
    </contact>
    <investigator>
      <last_name>Wayne Shreffler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Childrens' Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynda Schneider, MD</last_name>
      <phone>617-355-6000</phone>
      <email>lynda.schneider@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Lynda Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute</name>
      <address>
        <city>Plymouth</city>
        <state>Minnesota</state>
        <zip>55441</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allan Stillerman, MD</last_name>
      <phone>763-744-1140</phone>
      <email>as@allergy-asthma-docs.com</email>
    </contact>
    <investigator>
      <last_name>Allan Stillerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Mercy Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Dowling, MD</last_name>
      <phone>816-960-8885</phone>
      <email>pdowling@cmh.edu</email>
    </contact>
    <investigator>
      <last_name>Paul Dowling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Asthma and Allergy Center</name>
      <address>
        <city>Bellevue</city>
        <state>Nebraska</state>
        <zip>68123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Ford, MD</last_name>
      <phone>402-592-2055</phone>
      <email>lford@asthmaandallergycenter.com</email>
    </contact>
    <investigator>
      <last_name>Linda Ford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Nowak-Wegrzyn, MD</last_name>
      <phone>212-241-5548</phone>
      <email>anna.nowak-wegrzyn@mssm.edu</email>
    </contact>
    <investigator>
      <last_name>Anna Nowak-Wegrzyn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of North Carolina - Chapell Hill</name>
      <address>
        <city>Chapell Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edwin Kim, MD</last_name>
      <phone>919-843-9087</phone>
      <email>edwinkim@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Edwin Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terri Brown-Whitehorn, MD</last_name>
      <phone>215-590-2549</phone>
      <email>brownte@email.chop.edu</email>
    </contact>
    <investigator>
      <last_name>Terri Brown-Whitehorn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Green, MD</last_name>
      <phone>412-692-8296</phone>
      <email>todd.green@chp.edu</email>
    </contact>
    <investigator>
      <last_name>Todd Green, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Allergy and Asthma Research</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ned Rupp, MD</last_name>
      <phone>843-797-8162</phone>
      <email>NRupp@nationalallergyandasthma.com</email>
    </contact>
    <investigator>
      <last_name>Ned Rupp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Medical Center of Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Drew Bird, MD</last_name>
      <phone>214-456-5142</phone>
      <email>drew.bird@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Drew Bird, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine - Texas Children's Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davis Carla, MD</last_name>
      <phone>832-824-1319</phone>
      <email>cmdavis@texaschildrens.org</email>
    </contact>
    <investigator>
      <last_name>Davis Carla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sylvana Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Ratner, MD</last_name>
      <phone>210-614-6673</phone>
      <email>paulratner@sylvanaresearch.com</email>
    </contact>
    <investigator>
      <last_name>Paul Ratner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>STAAMP Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Gonzales-Reyes, MD</last_name>
      <phone>210-573-2451</phone>
      <email>txallergydoc@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Erika Gonzales-Reyes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASTHMA, Inc. Clinical Research</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98115-2060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Tilles, MD</last_name>
      <phone>206-525-5520</phone>
      <email>stilles@nwasthma.com</email>
    </contact>
    <investigator>
      <last_name>Stephen Tilles, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's and Women's Health Centre of Brisith Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan Edmond, MD</last_name>
      <phone>604-875-2118</phone>
      <email>EChan5@cw.bc.ca</email>
    </contact>
    <investigator>
      <last_name>Chan Edmond, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alpha Medical Research Inc.</name>
      <address>
        <city>Mississauga</city>
        <state>Ontario</state>
        <zip>L5A 3V4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amarjit Cheema, MD</last_name>
      <phone>905-566-0555</phone>
      <email>acheema@crinc.ca</email>
    </contact>
    <investigator>
      <last_name>Amarjit Cheema, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ottawa Allergy Asthma Research Institute</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1G 6C6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Yang, MD</last_name>
      <phone>0016137252113</phone>
      <email>wyang@yangmedicine.com</email>
    </contact>
    <investigator>
      <last_name>William Yang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gordon Sussman Clinical Research Inc.</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4V 1R2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gordon Sussman, MD</last_name>
      <phone>0014169448333</phone>
      <email>gsussman@rogers.com</email>
    </contact>
    <investigator>
      <last_name>Gordon Sussman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Sainte Justine</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe Bégin</last_name>
      <phone>514-567-9599</phone>
      <email>philippe.begin@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Philippe Bégin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre De Recherche Applique</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4W2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rémi Gagnon, MD</last_name>
      <phone>418 659-7741</phone>
      <email>rgagnon@csacqc.ca</email>
    </contact>
    <investigator>
      <last_name>Rémi Gagnon, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 20, 2017</lastchanged_date>
  <firstreceived_date>September 26, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Peanut Hypersensitivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
